Introduction
============

Chronic pancreatitis (CP) is a chronic inflammatory disease in which pancreatic tissue and function are irreversibly altered. CP is characterized by irreversible progressive damage to the exocrine and endocrine functions of the pancreas, which ultimately leads to exocrine insufficiency (maldigestion) and diabetes.^\[[@R1]\]^ About 4% of patients developed pancreatic cancer.^\[[@R2]\]^ The main pathological manifestation of CP is fibrosis of the pancreas, which is due to the deposition of a large number of extracellular matrix.^\[[@R3]\]^ In the past few years, the pathogenesis of pancreatic fibrosis has received increasing attention, along with the identification and characterization of pancreatic stellate cells (PSCs).^\[[@R4],[@R5]\]^ PSCs are the main source of extracellular matrix, and excessive activation of PSCs contributes to the development of pancreatic fibrosis.^\[[@R6]--[@R8]\]^ Therefore, understanding the molecular mechanisms of over-activation of PSCs may pave the way for new treatments of CP.

The thromboxane A2 receptor (TxA~2~r) is a seven-transmembrane G-protein-coupled receptor.^\[[@R9],[@R10]\]^ Our previous study confirmed that TxA~2~r was overexpressed in PSCs following pancreatic injuries in high-fat diet (HFD)-treated rats.^\[[@R11]\]^ Moreover, the expression of the TxA~2~r is correlated with the expression of the fibrosis marker α-smooth muscle actin (α-SMA) in PSCs. Up-regulation of α-SMA expression in PSCs suggests that PSCs are activated, but it is unclear whether TxA~2~r is involved in the activation of PSCs. In addition, the upstream signal of up-regulation of the TxA~2~r is not fully understood.

There is increasing evidence that oxidative stress is involved in the activation of PSCs in CP.^\[[@R7],[@R12]--[@R14]\]^ In the oxidative stress response, a series of prostaglandin F-like compounds,^\[[@R15]\]^ called F2-isoprostanes have been produced, which are currently considered to be the most reliable markers of oxidative stress.^\[[@R16]--[@R18]\]^ 8-epi-prostaglandin F~2α~ (8-epi-PGF~2α~) is a relatively abundant member of the F2-isoprostane family and is the most representative isomer.^\[[@R19]--[@R21]\]^ 8-epi-PGF~2α~ induced hepatic stellate cell (HSC) proliferation and collagen production mediated liver fibrosis.^\[[@R22]--[@R24]\]^ In addition, a recent study showed that the effect of 8-epi-PGF~2α~ on HSCs is dependent on the expression of the prostaglandin-related receptor TxA~2~r.^\[[@R23],[@R25]\]^ Therefore, we hypothesized that 8-epi-PGF~2α~ might promote PSC activation mediated through TxA~2~r. The purpose of this study was to investigate the role of TxA~2~r in the activation of PSCs induced by 8-epi-PGF~2α~.

Methods
=======

Ethical approval
----------------

This protocol was approved by the Institutional Animal Care and Use Committee of Capital Medical University and complied with the NIH Laboratory Animal Care and Use Guidelines (NIH Publication No. 80-23). Every effort was made to reduce the number of animals and minimize their suffering.

Isolation and culture of PSCs
-----------------------------

Briefly, the pancreas of male Sprague-Dawley rats (180--200 g, *n* = 30) were digested with Gey balanced salt solution (GBSS) containing collagenase P (0.05%), pronase (0.02%), and DNase (0.1%). Then the resultant cell suspension was gently mixed with a 28.7% (wt/vol) Nycodenz gradient and centrifuged at 1400×*g*, 4°C for 20 min. After centrifugation, the stellate cells were enriched in the fuzzy band between the Nycodenz cushion and the GBSS with albumin from bovine serum. The PSCs were harvested from the band, and washed and resuspended in Iscove modified Dulbecco medium (IMDM) with 4 mmol/L glutamine, 10% fetal calf serum and antibiotics (streptomycin 100 μg/mL and penicillin 100 U/mL). Freshly isolated cells were seeded at (50--100) × 10^3^ cells/well in uncoated plastic six-well plate in IMDM containing 10% fetal bovine serum and incubated for 24 h (quiescent cells) or 48 h (activated cells).

TxA~2~r immunocytochemistry on PSCs
-----------------------------------

Activated PSCs grown on glass coverslips were fixed with cold acetone for 5 min at 4°C. The cells were washed twice with phosphate-buffered saline (PBS) and blocked with 3% bovine serum albumin (BSA) for 1 h. The cells were then incubated with a polyclonal antibody (1:100 in 3% BSA) against the human thromboxane (TX) A~2~/prostaglandin (PG) H~2~ (TP) receptor^\[[@R26]\]^ for 1 h. An EliVision™ Plus kit (Maixin Bio, Fuzhou, Fujian, China) was used to visualize the staining according to the manufacturer\'s instructions. Sections were incubated with a post-blocking reagent for 20 min at room temperature. After the sections were washed, secondary antibodies recognized by an EliVision Plus kit (Maixin Bio) were applied for 30 min at room temperature. The visualization signal was developed with diaminobenzidine. Cells were counterstained with Mayer hematoxylin for 5 min. The group of cells without primary antibody incubation were the negative controls.

Co-localization of α-SMA and TxA~2~r in PSCs
--------------------------------------------

Activated PSC was plated on glass coverslips and incubated for 24 h. The fixation of the cells is described as above. For immunofluorescence localization of α-SMA, the fixed cells were first blocked with 3% BSA, then incubated with monoclonal mouse antibody anti-α-SMA (clone 1A4; Neomarkers, Lab Vision, Fremont, CA, USA) (1:10) for 1 h, and finally incubated for 1 h with fluorescein isothiocyanate-conjugated anti-mouse immunoglobulin (IgG) (Jackson Immunoresearch, Lancaster, PA, USA) (1:200). Subsequently, the immunofluorescence localization of TxA~2~r was performed in the same procedure as α-SMA, except that the primary antibody was replaced with a rabbit polyclonal antibody against human TP receptor (1:100), and the fluorescent secondary antibody was replaced by Alexa Fluor 594-conjugated anti-rabbit IgG (1:200). Each time the solution was changed, it was washed with PBS for 1 min, three times. The results of immunofluorescence were observed under a Nikon Eclipse TE300 microscope (Nikon Corporation, Tokyo, Japan).

Immunoblot analysis of TxA~2~r in PSCs
--------------------------------------

Freshly isolated PSCs were trypsinized at 4°C for 5 min and collected, and then lysed with pre-cooled radio-immunoprecipitation assay lysis buffer (600 μL; 1% sodium deoxycholate, 1 mmol/L disodium ethylenediamine tetraacetate, 0.1% sodium dodecyl sulfate, 150 mmol/L sodium chloride, 1% Triton X-100, 50 mmol/L Tris-base; Beyotime Institute of Biotechnology, Shanghai, China) for 30 min on ice. The lysate of cells was centrifuged at 4°C, 12,000 r/min for 10 min. The supernatant was transferred to a 1.5 mL tube. And protein concentration was determined using Pierce BCA Protein Assay Kit (RTP7102, Real-Times Biotechnology Co., Ltd, Beijing, China). The samples were mixed with loading buffer and then denatured in boiling water bath for 10 min. Next, samples (20 μg/sample) were subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) at 100 V for 1 h. The proteins in gel after SDS-PAGE were transferred to polyvinylidene difluoride membranes using Western blotting transfer system (250 mA, 1 h) on ice. The blocking reaction used 5% skimmed milk for 1 h. Then, the membranes were incubated with a solution containing antibody of TxA~2~r (1:1000, BioRad, Hercules, CA, USA) or antibody of β-actin (1:1000; Abcam, Cambridge, UK) overnight at 4°C. After washing with PBS containing 1% Tween 20 for 5 min and for five times, the membranes were incubated with a solution including goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (1:1000; Abcam) for 1 h. Then, immunodetected proteins were visualized using an electrochemiluminescence assay kit (Amersham Biosciences, Piscataway, NJ, USA) according to the manufacturer\'s recommended protocol.^\[[@R27]\]^ Image lab v3.0 software (Bio-Rad, Hercules, California, USA) was used to acquire and analyze imaging signals. The relative contents of TxA~2~r in samples were normalized to β-actin.

Quantitation of messenger RNA (mRNA) with real-time polymerase chain reaction (RT-PCR)
--------------------------------------------------------------------------------------

The extraction of total RNA used TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA). The concentration of RNA was measured by Nanodrop ND2000 (Thermo Fisher Scientific). Then, reverse transcription was performed with 1 μg of total RNA to obtain complementary DNA using an Ipsogen RT kit (Qiagen, Hilden, Germany). The QuantiNova SYBR Green PCR Kit (Qiagen) was used for quantitative polymerase chain reaction (PCR). The sequences of primers were as follows: α-SMA (GGGATCCTGACCCTGAAGTA; CACGCGAAGCTCGTTATAGA) and collagen I (CGTGGAAACCTGATGTATGC; GGTTGGGACAGTCCAAGTCT). Expression levels were normalized to β-actin. The RT-PCR experimental procedure was repeated three times.

Treatment of 8-epi-PGF~2α~ or SQ29548 for PSCs
----------------------------------------------

PSCs isolated from four rats were seeded in six-well cell plates and cultured for 24 h. Cells were then treated with 8-epi-PGF~2α~ (10^−6^, 10^−7^, 10^−8^ mol/L) or SQ29548, a TxA~2~r-specific antagonist, (10^−4^, 10^−6^, and 10^−7^ mol/L) for 48 h, respectively to identify the drug concentration with the best biological effect and the least cytotoxicity. Then isolated PSCs were treated with SQ29548 (10^−4^ mol/L) for 2 h, followed by 10^−7^ mol/L 8-epi-PGF~2α~ for 48 h. The mRNA expression levels of α-SMA and collagen I were quantified by RT-PCR. The RT-PCR experimental procedure is described above. The experiment was repeated three times.

Statistical analysis
--------------------

Statistical analysis was performed using SPSS 20.0 statistical software (IBM, Armonk, NY, USA). The continuous data were shown as the mean ± standard deviation, and the normality of the data was checked using the Kolmogorov-Smirnov test. Comparisons between the two groups were performed using Student\'s *t* test. *P* \< 0.05 indicates that the difference was statistically significant.

Results
=======

TxA~2~r is up-regulated in cultured activated PSCs *in vitro*
-------------------------------------------------------------

First, the protein level of TxA~2~r in primary PSCs was measured by immunocytochemistry. The immunohistochemistry (IHC) staining showed that TxA~2~r was expressed in PSCs \[Figure [1](#F1){ref-type="fig"}A\]. The co-localization of α-SMA and TxA~2~r in PSCs staining showed that TxA~2~r was expressed in quiescent PSCs \[Figure [1](#F1){ref-type="fig"}B--D\]. After 48 h culture, the expression of TxA~2~r and α-SMA in PSCs was detected by immunofluorescent staining. As shown in Figure [2](#F2){ref-type="fig"}, TxA~2~r was also expressed in activated PSCs. Furthermore, compared to quiescent PSCs, the expression of TxA~2~r was increased in activated PSCs (all *P* \< 0.001) \[Figure [3](#F3){ref-type="fig"}\]. Collectively, these data showed that TxA~2~r was expressed both in quiescent and activated PSCs and its increased level was associated with the activation of PSCs.

![Immunocytochemistry of TxA~2~r in PSCs. (A) The expression of TxA~2~r in PSCs was confirmed by immunocytochemistry. The figure showed that TxA~2~r was localized to the cell surface and intracellularly. In particular, TxA~2~r immunoreactivity was predominantly detected in the perinuclear cytoplasm (A, original magnification ×400). (B) Showed no α-SMA staining in quiescent PSCs. (C) Showed TxA~2~r staining in PSCs. (D) Co-localization of TxA~2~r and α-SMA in PSCs by immunofluorescence double staining demonstrated that TxA~2~r was expressed in quiescent PSCs (B--D, original magnification ×200). TxA~2~r: Thromboxane A~2~ receptor; PSC: Pancreatic stellate cell; α-SMA: α-Smooth muscle actin.](cm9-133-1429-g001){#F1}

![Co-localization of TxA~2~r and α-SMA in PSCs by immunofluorescence double staining demonstrated that TxA~2~r was expressed in activated PSCs. (A) Showed that activated cells expressed α-SMA (red). (B) Showed that activated cells expressed TxA~2~r (green). The merged image showed the degree of co-localization in (C). (A--C, original magnification ×400). TxA~2~r: Thromboxane A~2~ receptor; α-SMA: α-Smooth muscle actin; PSC: Pancreatic stellate cell.](cm9-133-1429-g002){#F2}

![TxA~2~r protein expression in primary and passaged PSCs. We separated and cultured two groups of cells for Western blotting. Each sample was run in triplicate. (A) Incubation with a polyclonal antibody against the TP receptor revealed immunoreactivity for a 55,000-Da protein in lysates. (B) Statistical analysis indicated a significant difference between the passaged groups and the primary groups. Blots were re-probed with GAPDH to assess equal loading. GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; PSC: Pancreatic stellate cell; TP: Thromboxane (TX) A~2~/prostaglandin (PG) H~2~; TxA~2~r: Thromboxane A~2~ receptor. ^∗^*P* \< 0.001 *vs*. primary cells.](cm9-133-1429-g003){#F3}

TxA~2~r contributes to PSC activation *in vitro*
------------------------------------------------

To determine the role of TxA~2~r in PSC activation, SQ29548 was used to inhibit TxA~2~r in PSCs. Compared with the control, inhibiting TxA~2~r reduced the expression of collagen I at different concentrations of SQ29548 (10^−4^ mol/L: 0.55 ± 0.07 *vs.* 1.00 ± 0.07, *t* = 10.47, *P* *\<* 0.001; 10^−6^ mol/L: 0.56 ± 0.10 *vs.* 1.00 ± 0.07, *t* = 6.185, *P* *\<* 0.001; 10^−7^ mol/L: 0.27 ± 0.04 *vs.* 1.00 ± 0.07, *t* = 15.41, *P* *\<* 0.001) and α-SMA mRNA (10^−4^ mol/L: 0.06 ± 0.01 *vs.* 1.00 ± 0.11, *t* = 15.17, *P* *\<* 0.001; 10^−6^ mol/L: 0.28 ± 0.03 *vs.* 1.00 ± 0.11, *t* = 11.29, *P* *\<* 0.001; 10^−7^ mol/L: 0.14 ± 0.04 *vs.* 1.00 ± 0.11, *t* = 12.86, *P* *\<* 0.001) \[Figure [4](#F4){ref-type="fig"}\]. These data indirectly indicated that TxA~2~r contributed to PSC activation. mRNA level of α-SMA was the lowest after SQ29548 (10^−4^ mol/L) treatment. Thus, SQ29548 (10^−4^ mol/L) was used in subsequent experiments.

![Effect of SQ29548 on the relative mRNA expression levels of α-SMA (A) and collagen I (B) in PSCs. α-SMA: α-Smooth muscle actin; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; mRNA: Messenger RNA; PSC: Pancreatic stellate cell. ^∗^*P* \< 0.001 *vs*. the control.](cm9-133-1429-g004){#F4}

8-epi-PGF~2α~ promoted PSCs activation via inducing TxA~2~r
-----------------------------------------------------------

Different concentrations of 8-epi-PGF~2α~ were used to treat PSCs (10^−6^, 10^−7^, and 10^−8^ mol/L) for 48 h. mRNA levels of α-SMA and collagen I were quantitatively analyzed by RT-PCR \[Figure [5](#F5){ref-type="fig"}\]. Compared with the control group, 8-epi-PGF~2α~ increased mRNA levels of α-SMA (10^−6^ mol/L: 2.23 ± 0.18 *vs.* 1.00 ± 0.07, *t* = 10.70, *P* \< 0.001; 10^−7^ mol/L: 2.91 ± 0.29 *vs.* 1.01 ± 0.08*, t* = 10.83, *P* \< 0.001; 10^−8^ mol/L: 1.67 ± 0.07 *vs.* 1.00 ± 0.08, *t* = 11.40, *P* \< 0.001) and collagen I (10^−6^ mol/L: 2.68 ± 0.09 *vs.* 1.00 ± 0.07, *t* = 24.94, *P* \< 0.001; 10^−7^ mol/L: 2.12 ± 0.29 *vs.* 1.01 ± 0.12*, t* = 6.08, *P* \< 0.001; 10^−8^ mol/L: 1.46 ± 0.15 *vs.* 1.00 ± 0.05, *t* = 4.93, *P* = 0.008) in PSCs. Meanwhile, given that mRNA expression of α-SMA was the highest after 8-epi-PGF~2α~ (10^−7^ mol/L) treatment, 8-epi-PGF~2α~ (10^−7^ mol/L) was used in subsequent experiments. Then, the isolated PSCs were treated with SQ29548 (10^−4^ mol/L) for 2 h, followed by 10^−7^ mol/L 8-epi-PGF~2α~ for 48 h. As shown in Figure [6](#F6){ref-type="fig"}, SQ29548 10^−4^ mol/L significantly reduced 8-epi-PGF~2α~-induced mRNA expression of α-SMA (0.20 ± 0.08 *vs.* 1.00 ± 0.00, *t* = 17.46, *P* \< 0.001) and collagen I (0.69 ± 0.13 *vs.* 1.00 ± 0.00, *t* = 4.20, *P* = 0.014) in PSCs as compared with the control group. Together, these results suggested that 8-epi-PGF~2α~ promoted PSCs activation via inducing TxA~2~r.

![Effect of 8-epi-PGF~2α~ on the relative mRNA expression levels of α-SMA (A) and collagen I (B) in PSCs. 8-epi-PGF~2α~: 8-epi-prostaglandin F~2α~; α-SMA: α-Smooth muscle actin; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; mRNA: Messenger RNA; PSC: Pancreatic stellate cell. ^∗^*P* \< 0.05 *vs*. the control.](cm9-133-1429-g005){#F5}

![Effect of SQ29548 and 8-epi-PGF~2α~ on the relative mRNA expression levels of α-SMA (A) and collagen I (B) in PSCs. 8-epi-PGF~2α~: 8-epi-prostaglandin F~2α~; α-SMA: α-Smooth muscle actin; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; mRNA: Messenger RNA; PSC: Pancreatic stellate cell. ^∗^*P* \< 0.05 *vs*. the control.](cm9-133-1429-g006){#F6}

Discussion
==========

There is growing recognition that persistent oxidative stress may play a role in the development and maintenance of CP. Oxidative stress triggers pancreatic inflammation and fibrogenesis via the nuclear factor-κB signaling pathway.^\[[@R28]\]^ Inhibiting oxidative stress by scoparone protects against pancreatic fibrosis via the transforming growth factor-β/Smad signaling pathway in rats.^\[[@R29]\]^ In our previous study, increased expression of malondialdehyde and decreased superoxide dismutase activity were observed in rat pancreatic tissues under HFD treatment.^\[[@R11]\]^ In our present study, we explore the underlying mechanism by which oxidative stress triggers CP, with a focus on TxA~2~r and PSCs.

PSC activation has been reported to play a critical role in the development of CP. However, the underlying mechanism remains unclear. The distribution and expression of TxA~2~r in pancreatic tissues were demonstrated by immunohistochemical staining in our previous study. TxA~2~r was up-regulated in rat pancreatic tissues under chronic pancreatic injuries induced by HFD, and TxA~2~r was associated with α-SMA expression in activated PSCs.^\[[@R11]\]^ Our present study showed that up-regulated TxA~2~r may contribute to the activation of PSCs. Immunocytochemistry showed that TxA~2~r was localized to the cell surface and perinuclear cytoplasm in PSCs. Co-localization of TxA~2~r and α-SMA in PSCs by immunofluorescence double staining demonstrated that TxA~2~r was expressed in activated PSCs. Inhibiting TxA~2~r by SQ29548 significantly reduced the mRNA levels of α-SMA and collagen I in PSCs. To our knowledge, we are the first to provide a description of the relationship between TxA~2~r and PSC activation in CP.

Recent *in vitro* and *in vivo* research has proven that oxidative stress plays an important role in PSC activation.^\[[@R12],[@R29],[@R30]\]^ When PSCs are stimulated by an oxidative stress insult, these quiescent fat-storing cells become activated and subsequently trigger a downstream signal transduction cascade involving a further severe inflammatory process.^\[[@R31],[@R32]\]^ In response to stimuli such as inflammatory cytokines, chemokines or growth factors, activated PSCs produce more extracellular matrix products as well as various chemokines.^\[[@R33],[@R34]\]^ In our previous study, we conducted a double-immunofluorescence staining test and found that 4-hydroxynonenal was strongly localized within activated PSCs rather than quiescent PSCs.^\[[@R11]\]^ This result provided evidence that the activation of PSCs was directly related to lipid oxidation. In our present study, we confirmed that oxidative stress induced by 8-epi-PGF~2α~ promoted PSC activation *in vitro*.

Based on the oxidative stress hypothesis and experimental and clinical findings, antioxidant supplementation has been suggested as a potentially useful treatment for CP. Pre-clinical studies suggest that some antioxidants, including vitamin A, vitamin E, and epigallocatechin-3-gallate complex may be useful in relieving pain in CP.^\[[@R35]--[@R37]\]^ However, the development of clinical trials based on this novel concept is limited due to various reasons. In our present study, we found that 8-epi-PGF~2α~ promoted PSCs activation through the up-regulation of TxA~2~r, which may provide a new target for the treatment of CP. Due to the easy activation of PSCs *in vitro*, erroneous activation of PSCs will inevitably occur in the experimental data. Therefore, animal studies should be used in future research.

In conclusion, PSCs activation has been recognized to play a critical role in the development of CP. Oxidative stress is one of the most important underlying mechanisms in PSCs activation. In this study, we provided evidence that 8-Epi-PGF~2α~, an abundant member of the F2-isoprostanes, can induce PSCs activation *in vitro*. To explore the molecular mechanism of the activation of PSCs induced by 8-epi-PGF~2α~, we found that the expression of TxA~2~r was increased in activated PSCs. Further study showed that the TxA~2~r inhibitor SQ29548 significantly reduced the PSC activation by 8-epi-PGF~2α~. These results show that TxA~2~r may contribute to the activation of PSCs, and TxA~2~r may be a potential target for the treatment of CP.

Funding
=======

This study was supported by the grant from the National Natural Science Foundation Youth Fund (No. 81200325).

Conflicts of interest
=====================

None.

**How to cite this article:** Zhang XL, Li F, Cui YQ, Liu S, Sun HC. Thromboxane A~2~ receptor contributes to the activation of rat pancreatic stellate cells induced by 8-epi-prostaglandin F~2α~. Chin Med J 2020;133:1429--1435. doi: 10.1097/CM9.0000000000000838
